1 Ocak 2022 Dergi makalesi Açık Erişim

Ozkan, Serbay; Isildar, Basak; Ercin, Merve; Gezginci-Oktayoglu, Selda; Konukoglu, Dildar; Nesetoglu, Neset; Oncul, Mahmut; Koyuturk, Meral

Dublin Core

<?xml version='1.0' encoding='utf-8'?>
<oai_dc:dc xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
  <dc:creator>Ozkan, Serbay</dc:creator>
  <dc:creator>Isildar, Basak</dc:creator>
  <dc:creator>Ercin, Merve</dc:creator>
  <dc:creator>Gezginci-Oktayoglu, Selda</dc:creator>
  <dc:creator>Konukoglu, Dildar</dc:creator>
  <dc:creator>Nesetoglu, Neset</dc:creator>
  <dc:creator>Oncul, Mahmut</dc:creator>
  <dc:creator>Koyuturk, Meral</dc:creator>
  <dc:date>2022-01-01</dc:date>
  <dc:description>Background: The therapeutic potential of mesenchymal stem cells (MSCs)-derived conditioned media (CM) can be increased after preconditioning with various chemical agents. The aim of this study is comparative evaluation of effects of N-CM and DFS-CM which are collected from normal (N) and deferoxamine (DFS) preconditioned umbilical cord-derived MSCs on rat diabetic nephropathy (DN) model.</dc:description>
  <dc:identifier>https://aperta.ulakbim.gov.trrecord/261319</dc:identifier>
  <dc:identifier>oai:aperta.ulakbim.gov.tr:261319</dc:identifier>
  <dc:rights>info:eu-repo/semantics/openAccess</dc:rights>
  <dc:rights>http://www.opendefinition.org/licenses/cc-by</dc:rights>
  <dc:source>STEM CELL RESEARCH &amp; THERAPY 13(1)</dc:source>
  <dc:title>Therapeutic potential of conditioned medium obtained from deferoxamine preconditioned umbilical cord mesenchymal stem cells on diabetic nephropathy model</dc:title>
  <dc:type>info:eu-repo/semantics/article</dc:type>
  <dc:type>publication-article</dc:type>
</oai_dc:dc>